Abstract
Excipients are important components of pharmaceutical preparations that affect their quality, safety, and efficacy. Macrocyclic receptors are a family of supramolecular excipients with several advantages, including molecular-level protection, small sizes, fast kinetics of host-guest recognition, and modular construction. With the continuous advances in the medical field, personalized and precision medicine requires the development of excipients with low dosages, integrated modifying effects, universality, and controlled release. To meet these requirements, we have developed a new family of macrocyclic excipients based on calixarenes by integrating their covalent (broad chemical design space) and noncovalent (wide range of substrates) advantages. Accordingly, azocalixarenes (AzoCAs) were designed, showing high binding affinities to a broad spectrum of active pharmaceutical ingredients (APIs), selectivity to interferents, and responsiveness to hypoxic microenvironments. Due to their highly efficient and controllable recognition, AzoCAs serve as low-dose excipients for 30 APIs. Molecular encapsulation by AzoCAs results in the integrated modification of the physicochemical properties of APIs, including solubility, stability, bioavailability, and biocompatibility. Moreover, AzoCAs can be reduced by azoreductases overexpressed in hypoxic microenvironments, leading to the controlled release of APIs. Collectively, AzoCA excipients have broad application prospects for a series of diseases such as enteritis, arthritis, stroke, cancer, bacterial infection and kidney injury, with diverse therapeutic modalities, including chemotherapy, photodynamic therapy, photothermal therapy, immunotherapy, boron neutron capture therapy, radiotherapy, fluorescence imaging, and their combinations.
Similar content being viewed by others
References
Kingwell K. Nat Rev Drug Discov, 2020, 19: 823–824
Ting JM, Tale S, Purchel AA, Jones SD, Widanapathirana L, Tolstyka ZP, Guo L, Guillaudeu SJ, Bates FS, Reineke TM. ACS Cent Sci, 2016, 2: 748–755
Kalasz H, Antal I. Curr Med Chem, 2006, 13: 2535–2563
Braegelman AS, Webber MJ. Theranostics, 2019, 9: 3017–3040
Gu A, Wheate NJ. J Incl Phenom Macrocycl Chem, 2021, 100: 55–69
Webber MJ, Appel EA, Meijer EW, Langer R. Nat Mater, 2016, 15: 13–26
Lehn JM. Chem Soc Rev, 2017, 46: 2378–2379
Geng WC, Zheng Z, Guo DS. View, 2021, 2: 20200059
Pan YC, Wang H, Xu X, Tian HW, Zhao H, Hu XY, Zhao Y, Liu Y, Ding G, Meng Q, Ravoo BJ, Zhang T, Guo DS. CCS Chem, 2021, 3: 2485–2497
Da Silva E, Lazar AN, Coleman AW. J Drug Deliver Sci Tech, 2004, 14: 3–20
Barrow SJ, Kasera S, Rowland MJ, del Barrio J, Scherman OA. Chem Rev, 2015, 115: 12320–12406
Brewster ME, Loftsson T. Adv Drug Deliver Rev, 2007, 59: 645–666
He S, Wu L, Sun H, Wu D, Wang C, Ren X, Shao Q, York P, Tong J, Zhu J, Li Z, Zhang J. ACS Appl Mater Interfaces, 2022, 14: 38421–38435
Selinger AJ, Cavallin NA, Yanai A, Birol I, Hof F. Angew Chem Int Ed, 2022, 61: e202113235
Zeng Y, Zhou Z, Fan M, Gong T, Zhang Z, Sun X. Mol Pharm, 2017, 14: 81–92
Li JJ, Hu Y, Hu B, Wang W, Xu H, Hu XY, Ding F, Li HB, Wang KR, Zhang X, Guo DS. Nat Commun, 2022, 13: 6279
Huang Q, Hu ZY, Guo S, Guo DS, Wang R. SupraMolMater, 2022, 1: 100020
Hou X, Chang YX, Yue YX, Wang ZH, Ding F, Li ZH, Li HB, Xu Y, Kong X, Huang F, Guo DS, Liu J. Adv Sci, 2022, 9: e2104349
Cheng YQ, Yue YX, Cao HM, Geng WC, Wang LX, Hu XY, Li HB, Bian Q, Kong XL, Liu JF, Kong DL, Guo DS, Wang YB. J Nanobiotechnol, 2021, 19: 451
Hua B, Shao L, Li M, Liang H, Huang F. Acc Chem Res, 2022, 55: 1025–1034
Du X, Ma M, Zhang Y, Yu X, Chen L, Zhang H, Meng Z, Jia X, Chen J, Meng Q, Li C. Angew Chem Int Ed, 2023, 62: e202301857
Kwong CHT, Mu J, Li S, Fang Y, Liu Q, Zhang X, Kam H, Lee SMY, Chen Y, Deng F, Zhou X, Wang R. Chin Chem Lett, 2021, 32: 3019–3022
Wu JJ, Chen FY, Han BB, Zhang HQ, Zhao L, Zhang ZR, Li JJ, Zhang BD, Zhang YN, Yue YX, Hu HG, Li WH, Zhang B, Chen YX, Guo DS, Li YM. CCS Chem, 2023, 5: 885–901
Pan YC, Yue YX, Hu XY, Li HB, Guo DS. Adv Mater, 2021, 33: e2104310
Zheng Z, Geng WC, Li HB, Guo DS. SupraMol Chem, 2020, 33: 80–87
Wang H, Xu XX, Pan YC, Yan YX, Hu XY, Chen RW, Ravoo BJ, Guo DS, Zhang T. Adv Mater, 2021, 33: e2006483
Pan YC, Barba-Bon A, Tian HW, Ding F, Hennig A, Nau WM, Guo DS. Angew Chem Int Ed, 2021, 60: 1875–1882
Hazarika B, Singh VP. Chin Chem Lett, 2023, 34: 108220
Kuok KI, Li S, Wyman IW, Wang R. Ann New York Acad Sci, 2017, 1398: 108–119
Yin H, Bardelang D, Wang R. Trends Chem, 2021, 3: 1–4
Yao SY, Cai K, Guo DS. ActaPolym Sin, 2022, 53: 1271–1278
Petitjean M, Garcia-Zubiri IX, Isasi JR. Environ Chem Lett, 2021, 19: 3465–3476
Saokham P, Muankaew C, Jansook P, Loftsson T. Molecules, 2018, 23: 1161
Zhang TX, Zhang ZZ, Yue YX, Hu XY, Huang F, Shi L, Liu Y, Guo DS. Adv Mater, 2020, 32: e1908435
Ma X, Zhao Y. Chem Rev, 2015, 115: 7794–7839
Zhang Z, Yue YX, Xu L, Wang Y, Geng WC, Li JJ, Kong XL, Zhao X, Zheng Y, Zhao Y, Shi L, Guo DS, Liu Y. Adv Mater, 2021, 33: e2007719
Webber MJ, Langer R. Chem Soc Rev, 2017, 46: 6600–6620
Ferreira L, Campos J, Veiga F, Cardoso C, Paiva-Santos AC. Eur J Pharm BioPharm, 2022, 178: 35–52
Yao SY, Yue YX, Ying AK, Hu XY, Li HB, Cai K, Guo DS. Angew Chem Int Ed, 2023, 62: e202213578
Kumar R, Sharma A, Singh H, Suating P, Kim HS, Sunwoo K, Shim I, Gibb BC, Kim JS. Chem Rev, 2019, 119: 9657–9721
Kim HJ, Lee MH, Mutihac L, Vicens J, Kim JS. Chem Soc Rev, 2012, 41: 1173–1190
Wheate NJ, Limantoro C. SupraMol Chem, 2016, 28: 849–856
Conceição J, Adeoye O, Cabral-Marques HM, Lobo JMS. Drug Discov Today, 2018, 23: 1274–1284
Yue YX, Zhang Z, Wang ZH, Ma R, Chen MM, Ding F, Li HB, Li JJ, Shi L, Liu Y, Guo DS. Small Struct, 2022, 3: 2200067
Verwilst P, Han J, Lee J, Mun S, Kang HG, Kim JS. Biomaterials, 2017, 115: 104–114
Ma R, Zheng YD, Tian HW, Chen MM, Yue YX, Bian Q, Li HB, Guo DS. Pest Manag Sci, 2023, 79: 3133–3140
Zhang TX, Li JJ, Li HB, Guo DS. Front Chem, 2021, 9: 710808
Zhang Z, Yue YX, Li Q, Wang Y, Wu X, Li X, Li HB, Shi L, Guo DS, Liu Y. Adv Funct Mater, 2023, 33: 2213967
DeMatteo MP, Snyder NL, Morton M, Baldisseri DM, Hadad CM, Peczuh MW. J Org Chem, 2004, 70: 24–38
Yu G, Chen X. Theranostics, 2019, 9: 3041–3074
Zheng Z, Geng WC, Gao J, Wang YY, Sun H, Guo DS. Chem Sci, 2018, 9: 2087–2091
Xu Z, Jia S, Wang W, Yuan Z, Jan Ravoo B, Guo DS. Nat Chem, 2019, 11: 86–93
Biedermann F, Uzunova VD, Scherman OA, Nau WM, De Simone A. J Am Chem Soc, 2012, 134: 15318–15323
Li S, Ma R, Hu XY, Li HB, Geng WC, Kong X, Zhang C, Guo DS. Adv Mater, 2022, 34: e2203765
Hauss DJ. Adv Drug Deliver Rev, 2007, 59: 667–676
Zhao Y, Buck DP, Morris DL, Pourgholami MH, Day AI, Collins JG. OrgBiomol Chem, 2008, 6: 4509–4515
Mokhtari B, Pourabdollah K. Drug Chem Toxicol, 2013, 36: 119–132
Lu X, Isaacs L. Angew Chem Int Ed, 2016, 55: 8076–8080
Ghosh I, Nau WM. Adv Drug Deliver Rev, 2012, 64: 764–783
Ivanov AI, Christodoulou J, Parkinson JA, Barnham KJ, Tucker A, Woodrow J, Sadler PJ. J Biol Chem, 1998, 273: 14721–14730
Li B, Meng Z, Li Q, Huang X, Kang Z, Dong H, Chen J, Sun J, Dong Y, Li J, Jia X, Sessler JL, Meng Q, Li C. Chem Sci, 2017, 8: 4458–4464
Zhang L, Xiao Y, Yang QC, Yang LL, Wan SC, Wang S, Zhang L, Deng H, Sun ZJ. Adv Funct Mater, 2022, 32: 2201542
Guo DS, Uzunova VD, Su X, Liu Y, Nau WM. Chem Sci, 2011, 2: 1722
Geng WC, Sessler JL, Guo DS. Chem Soc Rev, 2020, 49: 2303–2315
Lutka A. Acta Pol Pharm, 2002, 59: 45–51
Tao G, Huang J, Moorthy B, Wang C, Hu M, Gao S, Ghose R. Expert Opin Drug Metab Toxicol, 2020, 16: 1109–1124
Hain BA, Waning DL. Curr Osteoporos Rep, 2022, 20: 433–441
Cucinotta V, Mangano A, Nobile G, Santoro AM, Vecchio G. J Inorg Biochem, 1993, 52: 183–190
Li JJ, Rong RX, Yang Y, Hu ZY, Hu B, Zhao YY, Li HB, Hu XY, Wang KR, Guo DS. Mater Horiz, 2023, 10: 1689–1696
Shao L, Pan Y, Hua B, Xu S, Yu G, Wang M, Liu B, Huang F. Angew Chem Int Ed, 2020, 59: 11779–11783
Gao J, Li J, Geng WC, Chen FY, Duan X, Zheng Z, Ding D, Guo DS. J Am Chem Soc, 2018, 140: 4945–4953
Gray VA, Rosanske TW. Chapter 18 - Dissolution. In: Riley CM, Reid G, Rosanske TW, Eds. Specification of Drug Substances and Products (Second Edition). Development and Validation of Analytical Methods. Amsterdam: Elsevier, 2020. 481–503
Shanmuga Priya A, Sivakamavalli J, Vaseeharan B, Stalin T. Int JBiol Macromol, 2013, 62: 472–480
Badr-Eldin SM, Elkheshen SA, Ghorab MM. Eur J Pharm Biopharm, 2008, 70: 819–827
Webb SD, Koval CA, Randolph CM, Randolph TW. Anal Chem, 2001, 73: 5296–5301
Wang L, Zhao X, Yang F, Wu W, Wu M, Li Y, Zhang X. Int J Biol Macromolecules, 2019, 138: 207–214
Arias MJ, Moyano JR, Ginés JM. Int J Pharm, 1997, 153: 181–189
Mura P, Faucci MT, Parrini PL. Drug Dev Industrial Pharmacy, 2001, 27: 119–128
Mao D, Liang Y, Liu Y, Zhou X, Ma J, Jiang B, Liu J, Ma D. Angew Chem Int Ed, 2017, 56: 12614–12618
Hu X, Lei B, Li SS, Chen LJ, Li Q. Responsive Mater, 2023, 1: e20230009
Eltzschig HK, Bratton DL, Colgan SP. Nat Rev Drug Discov, 2014, 13: 852–869
Geng WC, Jia S, Zheng Z, Li Z, Ding D, Guo DS. Angew Chem Int Ed, 2019, 58: 2377–2381
Zhang TX, Hou X, Kong Y, Yang F, Yue YX, Shah MR, Li HB, Huang F, Liu J, Guo DS. Theranostics, 2022, 12: 396–409
Mokhtari RB, Homayouni TS, Baluch N, Morgatskaya E, Kumar S, Das B, Yeger H. Oncotarget, 2017, 8: 38022–38043
Kolishetti N, Dhar S, Valencia PM, Lin LQ, Karnik R, Lippard SJ, Langer R, Farokhzad OC. Proc Natl Acad Sci USA, 2010, 107: 17939–17944
Mayer LD, Harasym TO, Tardi PG, Harasym NL, Shew CR, Johnstone SA, Ramsay EC, Bally MB, Janoff AS. Mol Cancer Ther, 2006, 5: 1854–1863
Miao L, Guo S, Zhang J, Kim WY, Huang L. Adv Funct Mater, 2014, 24: 6601–6611
Wang Y, Zhang Z, Zhao X, Xu L, Zheng Y, Li HB, Guo DS, Shi L, Liu Y. Theranostics, 2022, 12: 3747–3757
Pan YC, Hu XY, Guo DS. Angew Chem Int Ed, 2021, 60: 2768–2794
Acknowledgements
This work was supported by the National Natural Science Foundation of China (U20A20259, 22201141), the Fundamental Research Funds for the Central Universities, the NCC Fund (NCC2020FH04), and the China Postdoctoral Science Foundation (2022M711697).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest The authors declare no conflict of interest.
Additional information
Supporting information The supporting information is available online at chem.scichina.com and link.springer.com/journal/11426. The supporting materials are published as submitted, without typesetting or editing. The responsibility for scientific accuracy and content remains entirely with the authors.
Supporting Information
Rights and permissions
About this article
Cite this article
Yue, YX., Lin, YL., Chen, MM. et al. Azocalixarenes: a scaffold of universal excipients with high efficiency. Sci. China Chem. 67, 1697–1706 (2024). https://doi.org/10.1007/s11426-023-1857-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11426-023-1857-2